Novartis AG
Tricyclic compounds useful to treat orthomyxovirus infections

Last updated:

Abstract:

The present invention provides a compound of Formula (I) including pharmaceutically acceptable salts thereof: ##STR00001## and therapeutic uses of these compounds. The invention further provides pharmaceutical compositions comprising these compounds, compositions comprising these compounds with a therapeutic co-agent, and methods of using the compounds and compositions to treat viral infections.

Status:
Grant
Type:

Utility

Filling date:

7 Mar 2017

Issue date:

8 Dec 2020